Here's what you need to know about the AbbVie-Allergan deal
10.2 هزار بار بازدید -
5 سال پیش
-
AbbVie is buying Allergan for
AbbVie is buying Allergan for $188.24 per share, at a premium of almost 45 percent. The deal redomiciles Allergan as a U.S. company. CNBC's David Faber reports.
5 سال پیش
در تاریخ 1398/04/04 منتشر شده
است.
10,220
بـار بازدید شده